Skip to content
K12 Inc.'s (NYSE:LRN) price-to-earnings (or "P/E") ratio of 80x might make it look like a strong sell right now......
The European Union is reportedly in talks to make advance purchase deals of potential COVID-19 vaccines with drugmakers Moderna (MRNA), Sanofi (SNY) and Johnson & Johnson (JNJ) as well as biotech firms BioNtech (BNTX) and CureVac.The most advanced talks appear to be those with Johnson & Johnson and Sanofi because the EU is already discussing details on the number of doses needed, Reuters reported. With U.S. giant Johnson & Johnson, the EU is negotiating a supply of 200 million doses of its potential vaccine, the Reuters report said, adding that additional supplies may also be available.“We are in talks with several companies on possible COVID-19 vaccines,” a spokesman for the Commission told Reuters on Friday, declining to comment on specific firms as negotiations were confidential.In the second half of next year, the EU is also planning to secure 300 million doses of the potential vaccine developed by France’s Sanofi in cooperation...
Healthcare costs, Social Security and lifestyle choices should be considered before you act on an early retirement offer....
(Bloomberg) -- The tea leaves of the world’s biggest bond market are producing a much-more foreboding reading than those of U.S. stock prices.America’s equity indexes are holding well above their pandemic-induced 2020 lows, yet the Treasury market increasingly is foreshadowing doubt over the pace of the economic rebound as new virus cases slow re-opening plans in many states. Ten-year real yields, considered a more-pure read on growth since they strip out inflation, have dropped for the past six weeks and hover at about -0.85%.The Treasury market is charting its path based on the resurgent coronavirus and expectations that the Federal Reserve will push even harder on the monetary gas pedal, allowing inflation to run above its 2% target in the process. That has real rates, as measured by the yield on 10-year Treasury Inflation-Protected Securities, on course to potentially slide to as low -2% in the years ahead, according to Stephen...
It’s that time of year again. Earnings season is in full swing, and investors are bracing for some bad news as companies report their second quarter results. Ahead of the upcoming prints, the Street is calling for a sharp profit decline as a result of the COVID-19 pandemic and the heavy blow it dealt to the economy. While the results could be rough for many, the pros from RBC Capital argue that the health crisis has altered consumer behavior for the foreseeable future. To this end, the investment firm, which lands within the top four on TipRanks’ list of Top Performing Research Firms, reevaluated several large-cap names in its coverage universe before their earnings releases, locking in on two FAANG stocks poised to emerge from the crisis as winners. Using TipRanks’ database, we pulled up the details on these two stocks to find out how the rest of the Street thinks...
Lockheed Martin (LMT) has won a $15 billion contract to supply the U.S. Air Force with its C-130J Hercules transport aircraft.The contract was awarded for the development, integration and production of all the four variants of the military transport aircraft. The U.S. Air Force said that the contract is for an indefinite quantity and indefinite delivery. Work, which will be performed at Lockheed’s plant in Georgia, is expected to be completed July 16, 2030.The C-130J aircraft can carry tons of supplies more than 3,000 miles and deliver “the last mile” to remote operating bases, keeping trucks off dangerous highways. It operates with only two pilots and one loadmaster for most missions, exposing fewer flight crew members to potential combat threats. The aircraft is used by about 20 countries around the globe.“This contract involves foreign military sales and is the result of a sole-source acquisition” the U.S. Air Force said in a statement. “Fiscal 2018...
